US$ 21.02
semaglutide effect on heart and the Heart: clinical insights from the SELECT Trial Semaglutide in Cardiometabolic Diseases: SELECTing
Description
Michael E

Both Zepbound and Wegovy use semaglutide to reduce appetite, but they differ in formulation and access

Methods This was a substudy of a randomised clinical trial on the effects of semaglutide and empagliflozin alone or in combination

Evidence Rating Level: 1 (Excellent) Study Rundown: There is strong overlap between weight gain and type 2 diabetes, with the majority of diabetic patients being overweight or
New lower price for a limited time only

Storage: Store unreconstituted vials at 28C
